Stephen D. Nimer, M.D.
- Fax: 305-243-9161
- American Board of Internal Medicine
- American Board of Internal Med-Hematology
- American Board of Internal Med-Medical Oncology
- Hematology/Oncology - Internal Medicine
- Internal Medicine
- Director, Sylvester Comprehensive Cancer Center Professor of Medicine, Biochemistry & Molecular Biology
- Professor of Medicine
Leukemia Treatment Specialist
Lymphoma Treatment Specialist
-Epigenetic therapies of cancer
-Transcriptional regulation of normal and malignant hematopoiesis
-Stem cell biology
-Histone modifying enzymes
E. Donnall Thomas Award - Bone Marrow Foundation
Israel Cancer Research Fund-Florida Award
2014 The Life Raft Group - Humanitarian of the Year Award
Elected to the Association of American Physicians
NCI Independent Investigator Award (R01 CA166835-01)
“Invited member of the Faculty of 1000, within the Anemias and Hypocellular Marrow Disorders Section of Hematology.”
Awarded Alfred P. Sloan Endowed Chair
G & P Foundation “Angel of Hope” Award
NIH Independ. Investig. Award (R01 DK52621)
James Kuebel Memorial Lecture, Washington Univ. School of Med
Paul Sherlock Housestaff Teaching Award
Principal Investigator, LLS Specialized Center of Research Award “Specialized Center for the Study of Myeloid Malignancies” (renewed for 2006-2011)
Leukemia & Lymphoma Society, NY Chapter Researcher of the Year Award
Project II Leader, NCI Cancer Chemotherapy PPG (P01 CA05826, P.I.: G. Bosl)
Fenmore Visiting Lectureship
Gabrielle Rich Foundation Award
Sunshine Lady Foundation Award
Byrne Fund Grant Award
NIH Independent Investig. Award (RO1 DK52208), renewed 2008
Irma T. Hirschl Career Scientist Award
Seymour Feldman Leukemia Research Award
Lauri Strauss Leukemia Foundation Research Award
NIH Independent Investigator Award (RO1 DK43025)
Tobacco-Related Disease Research Progr. Grant, Univ. of California
Sasakawa Fund Award.
NIH Physician Scientist Award (K08)
M.D. with Honors
Joseph A. Capps Award for Proficiency in Clinical Medicine
Alpha Omega Alpha Honor Society
UCLA School of Medicine
1982 Internship and Residency
UCLA School of Medicine
University of Chicago (Pritzker) School of Medicine
Massachusetts Institute of Technology
- A stable transcription factor complex nucleated by oligomeric AML1-ETO controls leukaemogenesis.
- JAK2V617F-mediated phosphorylation of PRMT5 down-regulates its methyltransferase activity and promotes myeloproliferation.
- The leukemogenicity of AML1-ETO is dependent on site-specific lysine acetylation.
- All publications
Dr Nimer is an expert in treating leukemia and lymphoma.
A hematologist, molecular biologist, and bone marrow transplant physician, Dr. Nimer is currently the Director of the Sylvester Comprehensive Cancer Center at the University of Miami, Florida. Dr. Nimer was at Memorial Sloan-Kettering Cancer Center in New York for nearly 20 years, where he held the Alfred P. Sloan Chair and served as Head of the Division of Hematologic Oncology, Vice Chairman for Faculty Development, and Chief of the Hematology Service. He also served as a member of Sloan-Kettering Institute for Cancer Research, an Attending Physician at Memorial Hospital, and a Professor of Medicine and Pharmacology at Weill Medical College of Cornell University.
Over the years, Dr. Nimer has conducted extensive clinical and basic science research into the treatment and genetic basis of adult leukemia and bone marrow failure states, defining the regulatory mechanisms that control the production of blood cells and exploring ways to improve the treatment of blood based cancers. He has authored over 200 scientific publications and has received numerous awards for his research, including the prestigious Irma T. Hirschl Career Scientist Award. Dr. Nimer graduated from the Massachusetts Institute of Technology in 1975, and received his M.D. degree with honors from the University of Chicago of Medicine in 1979. He completed training in Internal Medicine and Hematology/Oncology at the UCLA School of Medicine, and joined the faculty there in 1986, before moving to Memorial Sloan-Kettering in 1993.
Dr. Nimer was elected to the American Society of Clinical Investigators at age 42, and is a Fellow of the American College of Physicians. He serves on the editorial board of several medical journals, and on the medical boards of the Myelodysplastic Syndrome Foundation, the Bone Marrow Foundation, and other foundations. Dr. Nimer is also the Chairman of the Medical Advisory Board of Gabrielle's Angel Foundation for Cancer Research.